Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Stephen R. Spellman"'
Autor:
Dennis Dong Hwan Kim, Jean-Yves Cahn, Olle Ringdén, Joseph Pidala, Margaret L. MacMillan, J. Schriber, Leo F. Verdonck, Mahmoud Aljurf, Joseph H. Antin, Robert K. Stuart, Ayman Saad, Mitchell S. Cairo, Eneida R. Nemecek, Ying Liu, David I. Marks, Daniel R. Couriel, Saurabh Chhabra, Stephen R. Spellman, Usama Gergis, Mukta Arora, Betty K. Hamilton, Christopher E. Dandoy, Taiga Nishihori, Yoshihiro Inamoto, Sung Won Choi, Bipin N. Savani, Amin M. Alousi, Christopher Bredeson, Edmund K. Waller, Gérard Socié, Robert Peter Gale, Navneet S. Majhail, Luciano J. Costa, Sachiko Seo, Mona Wirk, Rammurti T. Kamble, Takanori Teshima, Michael T. Hemmer, Peiman Hematti
Publikováno v:
Biol Blood Marrow Transplant
Combination therapy with a calcineurin inhibitor (CNI), such as cyclosporine (CSA) or tacrolimus (Tac), and methotrexate (MTX) or mycophenolate mofetil (MMF) is a widely used approach to graft-versus-host disease (GVHD) prevention. Data on the compar
Autor:
Ronald Sobecks, Jeffrey S. Miller, Michael Haagenson, Elizabeth Trachtenberg, Peter Parham, Steven G.E. Marsh, Todd Fehninger, Hati Kobusingye, Ashley Spahn, Steven M. Devine, Jenny Vogel, Edmund K. Waller, Sarah Cooley, Ann E. Woolfrey, Cynthia Vierra-Green, Lisbeth A. Guethlein, Daniel J. Weisdorf, Stephen R. Spellman, Tao Wang, Maureen Ross
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 25(1)
We previously reported that acute myelogenous leukemia (AML) transplants using killer cell immunoglobulin-type receptor (KIR) B haplotype better or best (≥2 B activating gene loci ± Cen B/B) unrelated donors (URDs) yield less relapse and better su
Autor:
Peter Parham, Stephanie J. Lee, Sarah Cooley, Steven G.E. Marsh, Stephen R. Spellman, Jeffrey S. Miller, Veronika Bachanova, Tao Wang, Nezih Cereb, Michael Haagenson, Lisbeth A. Guethlein, Daniel J. Weisdorf
Publikováno v:
Biol Blood Marrow Transplant
Allogeneic hematopoietic cell transplantation (alloHCT) remains the sole curative therapy for patients with chronic lymphocytic leukemia (CLL), leading to 40% to 45% long-term survival. The impact of donor killer immunoglobulin-like receptor (KIR) ge
Autor:
Sharon A. Savage, Youjin Wang, Stephen R. Spellman, Michael Haagenson, Shahinaz M. Gadalla, Stephanie J. Lee, Belynda Hicks, Kristine Jones, Tao Wang, Casey L. Dagnall
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 23(7)
Telomeres are tandem nucleotide repeats and a protein complex located at the end of the chromosomes maintaining genomic stability. Their potential as a predictive biomarker for outcomes after allogeneic hematopoietic cell transplant (HCT) in hematolo
Autor:
Stephen R. Spellman, Michael R. Verneris, Gretchen A. Hoff, Katharine C. Hsu, Michael Haagenson, Jeffrey S. Miller, Johannes C. Fischer, Stephanie J. Lee, Tao Wang, Jeffrey M. Venstrom, Sarah Cooley, Markus Uhrberg
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 23(1)
Natural killer cells are important in graft-versus-leukemia responses after hematopoietic cell transplantation (HCT). A variety of surface receptors dictates natural killer cell function, including killer cell immunoglobulin-like receptor recognition
Autor:
Tao Wang, Elizabeth Trachtenberg, Michael Haagenson, Veronika Bachanova, Stephen R. Spellman, Lisbeth A. Guethlein, Sarah Cooley, Daniel J. Weisdorf, Peter Parham, Steven G.E. Marsh, Martha Ladner, Jeffrey S. Miller
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(9)
Donor killer immunoglobulin-like receptor (KIR) genotypes are associated with relapse protection and survival after allotransplantation for acute myelogenous leukemia. We examined the possibility of a similar effect in a cohort of 614 non-Hodgkin lym
Autor:
Dennis L. Confer, John R. Wingard, Brent R. Logan, Galen E. Switzer, Linda J. Burns, Rebecca J. Drexler, Pintip Chitphakdithai, Stephen R. Spellman, John P. Miller, Claudio Anasetti
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 22(6)
We report a comparison of time to recovery, side effects, and change in blood counts from baseline to after donation from unrelated donors who participated in the Blood and Marrow Transplant Clinical Trials Network phase III randomized, multicenter t
Autor:
Theresa Hahn, Lara E. Sucheston-Campbell, Marcelo C. Pasquini, Stephen R. Spellman, Leah Preus, John A. Hansen, David Tritchler, Philip L. McCarthy, Xiaochun Zhu, Paul J. Martin, Li Yan, Kenan Onel, Alyssa Clay, Song Liu
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(9)
Clinical trials commonly use adjudication committees to refine endpoints, but observational research or genome-wide association studies rarely do. Our goals were to establish definitions of cause-specific death after unrelated-donor allogeneic hemato
Autor:
David B. Miklos, Mei-Jie Zhang, Stephen R. Spellman, Carl Grumet, Brent R. Logan, Robert S. Negrin, Aaron C Logan, Ruby M. Wong, Zhiyu Wang, Stephanie J. Lee, Tze Lai, Kamran Alimoghaddam
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 21(4)
We evaluated ABO associated outcomes in 1737 patients who underwent allogeneic hematopoietic cell transplantation (allo-HCT) at Stanford University between January 1986 and July 2011. Grafts were 61% ABO matched, 18% major mismatched (MM), 17% minor
Autor:
Victor M. Aquino, Theodore B Moore, Sonali Chaudhury, Shelly L. Carter, Michael Grimley, Jane Sande, Michael A. Pulsipher, Suhag Parikh, Joel A. Brochstein, Brian M. Freed, Mark C. Walters, Naynesh Kamani, John E. Levine, Mary Eapen, Stephen R. Spellman, Julie A. Panepinto, Shalini Shenoy, Brent R. Logan, Kirk R. Schultz
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 18(8)
The Sickle Cell Unrelated Donor Transplant Trial (SCURT trial) of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) is a phase II study of the toxicity and efficacy of unrelated donor hematopoietic cell transplantation in children wit